Selexipag is a selective non-prostanoid IP prostacyclin receptor agonist.
2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
Used to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs) to slow down the worsening of symptoms and reduce the chance of being hospitalized for PAH
Solid
Nuray’s expertise and experience lie in developing pharmaceutical industry’s chemistry requirements from the synthesis of NCEs,
Plot No.111, SIDCO Industrial Estate, Kakkalur, Thiruvallur 602 003 Tamilnadu, India.
044 66616700
044 35016700
+1(732)666-8660
Business - enquiry@nuraychemicals.com
Nuraychemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.
